Inhibitor of VEGF receptor and HGF receptor signaling

Details for Australian Patent Application No. 2006343808 (hide)

Owner MethylGene Inc.

Inventors Claridge, Stephen William; Raeppel, Franck; Saavedra, Oscar Mario; Zhan, Lijie; Vaisburg, Arkadii

Agent Freehills

Pub. Number AU-B-2006343808

PCT Pub. Number WO2008/041053

Priority 60/683,036 20.05.05 US; 60/785,054 22.03.06 US; 60/754,902 29.12.05 US

Filing date 19 May 2006

Wipo publication date 10 April 2008

Acceptance publication date 29 March 2012

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 April 2008 Alteration of Name

  The name of the applicant has been altered to MethylGene Inc. 2007

11 February 2010 PCT application entered the National Phase

  PCT publication WO2008/041053 Priority application(s): WO2008/041053

13 January 2011 Assignment before Grant

  MethylGene Inc. The application has been assigned to MethylGene Inc. 2007

29 March 2012 Application Accepted

  Published as AU-B-2006343808

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006343832-New benzothiazinone derivatives and their use as antibacterial agents

2006343807-Nanoparticulate solar control concentrates